Literature DB >> 2935883

Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat.

J C McKenzie, I Tanaka, T Inagami, K S Misono, R M Klein.   

Abstract

Distension of the atrial wall has been proposed as a signal for the increased release of atrial natriuretic factor (ANF) from atrial myocytes in response to perceived volume overload. To determine whether pressure changes resulting from hypertension in the pulmonary circulation may stimulate release of ANF, rats were exposed to chronic hypobaric hypoxia for 3 or 21 days and the ANF concentration in the atria and plasma were determined by specific radioimmunoassay. Exposure to chronic hypoxia resulted in significant increases in hematocrit at both 3 (p less than 0.025) and 21 days (p less than 0.005) and in the development of right ventricular hypertrophy (RVH) expressed as the ratio of the weight of the right ventricle to the weight of the left ventricle and septum (RV/LV+S) at both 3 (RV/LV+S = 0.278 +/- 0.005) and 21 days (RV/LV+S = 0.536 +/- 0.021). After 21 days, left atrial (LA) ANF content was significantly increased in hypoxic rats compared to controls (508 +/- 70 ng/mg tissue vs 302 +/- 37 ng/mg), while right atrial (RA) ANF content was significantly reduced (440 +/- 45 vs 601 +/- 58 ng/mg). At this time, plasma ANF concentration was significantly elevated compared to controls (238 +/- 107 pg/ml vs 101 +/- 10 pg/ml). These results suggest that the development of pulmonary hypertension following chronic hypobaric exposure induces altered atrial ANF content and increased plasma ANF concentration as a result of altered distension of the atrial wall.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935883     DOI: 10.3181/00379727-181-rc3

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  15 in total

1.  Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy.

Authors:  C J Friddle; T Koga; E M Rubin; J Bristow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Expression of the atrial natriuretic peptide gene in the cardiac muscle of rat extrapulmonary and intrapulmonary veins.

Authors:  D R Springall; M Bhatnagar; J Wharton; Q Hamid; S Gulbenkian; M Hedges; L Meleagros; S R Bloom; J M Polak
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

3.  Developmental changes in the rat atriopeptin hormonal system.

Authors:  Y F Wei; C P Rodi; M L Day; R C Wiegand; L D Needleman; B R Cole; P Needleman
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction.

Authors:  K Fujimoto; A Sakai; S Yoshikawa; S Shinozaki; Y Matsuzawa; K Kubo; T Kobayashi; G Ueda; M Sekiguchi; N F Voelkel
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Atrial natriuretic peptide during and after maximal and submaximal exercise under normoxic and hypoxic conditions.

Authors:  W Schmidt; G Brabant; C Kröger; S Strauch; A Hilgendorf
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

6.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Hemodynamic and humoral effects of atrial natriuretic peptide on pulmonary circulation after cardiac surgery.

Authors:  Keisuke Morimoto; Iwao Taniguchi; Shigeto Miyasaka; Shingo Ishiguro; Shigetsugu Ohgi
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

8.  Effects of atrial natriuretic peptide and nitroprusside on isolated pulmonary resistance and conduit arteries from rats with pulmonary hypertension.

Authors:  J C Wanstall; J S Thompson; A H Morice
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Normotensive normoxic men undergoing water diuresis fail to respond to stimulation of their peripheral arterial chemoreceptors by almitrine with an increase in plasma concentrations of atrial natriuretic factor.

Authors:  C Ledderhos; W Quies; A Bub; R Sanchez
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

10.  Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

Authors:  S Adnot; P Andrivet; P E Chabrier; J Piquet; P Plas; P Braquet; F Roudot-Thoraval; C Brun-Buisson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.